Research & Scholarship
Research Interests
Resistant Hypertension
Alcoholic Liver Disease
Presentations
Burt, L., Berlau D.J., Buffet L., Hanselin, M., Lalama, J., Sheridan, L., Sucher, B. (March 2, 2012) Overcoming Challenges in TBL: The Regis Approach, Team-Based Learning Collaborative, 11th Annual Team-Based Learning Collaborative, St. Petersburg, FL.
Hanselin, M.R., Saseen, J.J., Allen, R.R., Marrs, J.C., Nair, K.V., (October 18, 2011) Description of Antihypertensive Use in Patients with Resistant Hypertension Prescribed Four or More Agents, American College of Clinical Pharmacy, ACCP Annual Meeting , Pittsburgh, PA.
Hanselin, MR. (2011, May). Description of Antihypertensive Use in Patients with Resistant Hypertension Prescribed Four or More Agents. Presented at Western States Residency Conference. Pacific Grove, California.
Hanselin, MR. (2010, October). Primary Prevention of Cardiovascular Disease. Presented at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Aurora, Colorado.
Hanselin, MR. (2010, May). Anticoagulant Response to Standard Prophylactic Dosing of Unfractionated Heparin Based on Body Weight. Presented at Western States Residency Conference. Pacific Grove, California.
Hanselin, MR. (2010, May). Overview of Antiplatelet and Anticoagulant Agents. Presented at University of Colorado Hospital. Aurora, Colorado.
Hanselin, MR. (2009, December). Anticoagulant Response to Standard Prophylactic Dosing of Unfractionated Heparin Based on Body Weight. Poster presented at American Society of Health-System Pharmacists Midyear Clinical Meeting. Las Vegas, Nevada.
Publications
Hanselin, M. R., Saseen, J. J., Allen, R. R., Marrs, J. C., & Nair, K. V. (2011). Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension, 58(6), 1008–1013.
Hanselin MR, Vande Griende JP, Linnebur SA. INR Elevation Associated with Maitake Extract in Combination with Warfarin. The Annals of Pharmacotherapy. December 29, 2009;44(1):223-224.